Escondido, CA, United States of America

Howard Foyt

This inventor holds 1 USPTO granted patent. Top assignee: Cebix Ab. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Howard Foyt. Retrieved from https://idiyas.com/inventor/howard-foyt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Howard Foyt

Introduction

Howard Foyt is an accomplished inventor based in Escondido, California. He has made significant contributions to the field of medical technology, particularly in the treatment of diabetic subjects. His innovative approach has led to the development of a unique method that addresses microvascular impairment disorders.

Latest Patents

Foyt holds a patent for a method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide. This invention relates to PEGylated C-peptide derivatives that comprise at least one PEG group attached to the N-terminus. These derivatives exhibit improved pharmacokinetic and biological activity in vivo, showcasing Foyt's commitment to advancing medical treatments.

Career Highlights

Foyt is currently associated with Cebix Ab, a company focused on developing innovative therapies for diabetes and related conditions. His work at Cebix Ab has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions.

Collaborations

Some of Foyt's notable coworkers include John Wahren and Sheri Barrack. Their combined expertise contributes to the success of the projects they undertake together.

Conclusion

Howard Foyt's contributions to medical technology through his innovative patent demonstrate his dedication to improving the lives of those affected by diabetes. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…